Pulse Biosciences, Inc.
PLSE News Today: Stay Updated with the Latest Pulse Biosciences, Inc. News in Real Time
Find PLSE news now at Meyka AI. Stay informed with the latest Pulse Biosciences, Inc. stocks updates, including price news, market analysis, and expert insights.
Pre-market movers: 3778.T SAKURA Internet JPX JPY 3,470 Apr 2026: volume signal
3778.T stock jumps to JPY 3,470 pre-market on heavy volume; short-term momentum vs valuation trade-offs explained
^GSPC Today: April 06 — Dubai Arrests on Drone Posts Cloud Travel Risk
Dubai flight attendant arrest spotlights UAE cybercrime law. We assess Dubai travel risk, S&P 500 reaction, and practical steps for Singapore investors today.
YRI.TO Yamana Gold Inc. (TSX) intraday most active 06 Apr 2026: model target CAD 13.08
YRI.TO stock intraday update: price C$7.89, volume 23,617,782; Meyka AI model target CAD 13.08
DMN stock: Trades at $0.002 on NASDAQ with 2.23B shares, monitor liquidity
DMN stock trades at $0.002 on NASDAQ with heavy volume. Quick fundamentals, Meyka AI grade, and a 12‑month forecast for traders.
Hercules Capital Posts Record $1.81B in Q1 Debt and Equity Commitments
Hercules Capital reported a record $1.81 billion in debt and equity commitments in Q1 2026, marking its strongest quarterly performance to date. This is a sharp rise from about $1.02 billion in Q1 2025, showing growing demand for venture debt. The funding supported 28 companies, including both new and existing clients. This surge comes at…
Mark Gibbens’ Top Tech Stocks to Watch: Palantir, Nvidia, & JPMorgan
Global tech stocks saw sharp swings in early 2026, with AI leaders correcting after a strong 2024-2025 rally. As of March 2026, valuations across major tech firms have cooled, creating fresh entry points for investors. Amid this shift, top CIO Mark Gibbens has highlighted a focused list of stocks that could benefit from the next…
Neurocrine Biosciences Close to $2.5B Acquisition of Soleno Therapeutics
We’re seeing a major move in biotech today. Neurocrine Biosciences is close to completing a deal to acquire Soleno Therapeutics in a transaction worth more than $2.5 billion, potentially rising to about $2.9 billion in cash. This deal is one of the most notable biotech acquisitions so far in 2026, and it aligns with Neurocrine’s growth strategy…
Down 50% to C$0.005: BRAS.CN Nordique Resources Inc. (CNQ) 06 Apr 2026, key risk
BRAS.CN stock down 50% to C$0.005 on 06 Apr 2026; we examine valuation, liquidity and Meyka forecast
6597.T stock up 43% to JPY 3000 on JPX close 06 Apr 2026: strong volume may sustain gains
6597.T stock jumps 43% to JPY 3000 on JPX close 06 Apr 2026; volume surge and fundamentals examined